INOVIO PHARMACEUTICALS, INC.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Mar 2016 | $8.1M | $-15.5M | $-8.0M |
| Jun 2016 | $6.2M | $-18.2M | $-18.7M |
| Sep 2016 | $12.5M | $-20.2M | $-20.8M |
| Dec 2016 | $8.5M | $-22.4M | $-26.2M |
| Mar 2017 | $10.4M | $-21.9M | $-23.1M |
| Jun 2017 | $20.4M | $-9.6M | $-9.5M |
| Sep 2017 | $2.6M | $-29.2M | $-34.1M |
| Dec 2017 | $8.8M | $-22.9M | $-21.5M |
| Mar 2018 | $1.5M | $-32.7M | $-32.4M |
| Jun 2018 | $24.4M | $-5.2M | $-6.6M |
| Sep 2018 | $2.0M | $-26.6M | $-25.0M |
| Dec 2018 | $2.5M | $-29.5M | $-33.0M |
| Mar 2019 | $2.8M | $-28.5M | $-29.2M |
| Jun 2019 | $135.7K | $-28.2M | $-29.4M |
| Sep 2019 | $866.9K | $-24.0M | $-23.1M |
| Dec 2019 | $279.5K | $-30.4M | $-37.7M |
| Mar 2020 | $1.3M | $-25.2M | $-32.5M |
| Jun 2020 | $267.2K | $-33.2M | $-128.7M |
| Sep 2020 | $236.2K | $-36.3M | $19.2M |
| Dec 2020 | $5.6M | $-29.3M | $-24.3M |
| Mar 2021 | $371.1K | $-52.6M | $-54.4M |
| Jun 2021 | $272.8K | $-83.2M | $-82.1M |
| Sep 2021 | $291.7K | $-60.0M | $-60.2M |
| Mar 2022 | $199.1K | $-71.7M | $-79.1M |
| Jun 2022 | $784.4K | $-104.1M | $-108.5M |
| Sep 2022 | $9.2M | $-35.8M | $-37.8M |
| Mar 2023 | $114.9K | $-44.0M | $-40.6M |
| Jun 2023 | $226.0K | $-37.0M | $-35.5M |
| Sep 2023 | $388.4K | $-35.6M | $-33.9M |
| Mar 2024 | $0 | $-31.5M | $-30.5M |
| Jun 2024 | $100.8K | $-33.2M | $-32.2M |
| Sep 2024 | $0 | $-27.3M | $-25.2M |
| Mar 2025 | $65.3K | $-25.1M | $-19.7M |
| Jun 2025 | $0 | $-23.1M | $-23.5M |
| Sep 2025 | $0 | $-21.2M | $-45.5M |